AAAAAA

   
Results: 1-7 |
Results: 7
MITOXANTRONE (M) AND TAXOL (T) AS FIRST LINE CHEMOTHERAPY IN PATIENTSWITH ADVANCED BREAST-CANCER (ABC)
Authors: DICOSTANZO F SDROBOLINI A MANZIONE L BILANCIA D DINOTA A ROCCA A GASPERONI S GIUSTINI L ACITO L COLOZZA MA GORI S MOSCONI AM CONTU A
Citation: F. Dicostanzo et al., MITOXANTRONE (M) AND TAXOL (T) AS FIRST LINE CHEMOTHERAPY IN PATIENTSWITH ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 111-111
A DOUBLE-BLIND RANDOMIZED STUDY OF ORAL CLODRONATE IN THE TREATMENT OF BONE METASTASES FROM TUMORS POORLY RESPONSIVE TO CHEMOTHERAPY
Authors: PIGA A BRACCI R FERRETTI B SANDRI P NORTILLI R ACITO L PANCOTTI A DIFURIA L CARLE F CELLERINO R
Citation: A. Piga et al., A DOUBLE-BLIND RANDOMIZED STUDY OF ORAL CLODRONATE IN THE TREATMENT OF BONE METASTASES FROM TUMORS POORLY RESPONSIVE TO CHEMOTHERAPY, Journal of experimental & clinical cancer research, 17(2), 1998, pp. 213-217
PHASE-I-II TRIAL OF MITOXANTRONE(M) AND TAXOL(T) IN ADVANCED BREAST-CANCER
Authors: GUISTINI L DICOSTANZO F SDROBOLINI A BILANCIA D VALENTI L ANGIONA S GASPERONI S BARTOLUCCI R ACITO L MANZIONE L
Citation: L. Guistini et al., PHASE-I-II TRIAL OF MITOXANTRONE(M) AND TAXOL(T) IN ADVANCED BREAST-CANCER, Breast, 6(5), 1997, pp. 320-320
MITOXANTRONE, FLUOROURACIL, AND L-FOLINIC ACID IN ANTHRACYCLINE-PRETREATED METASTATIC BREAST-CANCER PATIENTS
Authors: BASCIONI R GIORGI F SILVA RR ACITO L GIUSTINI L DESIGNORIBUS G GIULIODORI L TESTA E
Citation: R. Bascioni et al., MITOXANTRONE, FLUOROURACIL, AND L-FOLINIC ACID IN ANTHRACYCLINE-PRETREATED METASTATIC BREAST-CANCER PATIENTS, Breast cancer research and treatment, 45(3), 1997, pp. 205-210
GRANISETRON PLUS DEXAMETHASONE IN MODERATELY EMETOGENIC CHEMOTHERAPY - EVALUATION OF ACTIVITY DURING 3 CONSECUTIVE COURSES OF CHEMOTHERAPY
Authors: SILVA RR BASCIONI R GIORGI F ACITO L GIUSTINI L DESIGNORIBUS G MARCELLINI M MENICHETTI ET GIULIODORI L
Citation: Rr. Silva et al., GRANISETRON PLUS DEXAMETHASONE IN MODERATELY EMETOGENIC CHEMOTHERAPY - EVALUATION OF ACTIVITY DURING 3 CONSECUTIVE COURSES OF CHEMOTHERAPY, Supportive care in cancer, 4(4), 1996, pp. 287-290
HIGH-DOSE FOLINIC ACID AND FLUOROURACIL WITH OR WITHOUT IFOSFAMIDE ISAN INACTIVE COMBINATION IN ADVANCED PANCREATIC-CANCER - A RANDOMIZED PHASE-II STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC)
Authors: DICOSTANZO F TAGLIAVENTI M CARLINI P ZIRONI S MAZZOCCHI B BELLA M DONATI D ACITO L MAGGIAN P ANGIONA S
Citation: F. Dicostanzo et al., HIGH-DOSE FOLINIC ACID AND FLUOROURACIL WITH OR WITHOUT IFOSFAMIDE ISAN INACTIVE COMBINATION IN ADVANCED PANCREATIC-CANCER - A RANDOMIZED PHASE-II STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), American journal of clinical oncology, 19(3), 1996, pp. 307-310
A PHASE-II RANDOMIZED TRIAL OF 5-FLUOROURACIL WITH OR WITHOUT INTERFERON ALPHA-2A IN ADVANCED COLORECTAL-CANCER
Authors: PIGA A CASCINU S LATINI L MARCELLINI M BAVOSI M ACITO L BASCIONI R GIUSTINI L FRANCINI G PANCOTTI A ROSSI G DELPAPA M CARLE F CELLERINO R
Citation: A. Piga et al., A PHASE-II RANDOMIZED TRIAL OF 5-FLUOROURACIL WITH OR WITHOUT INTERFERON ALPHA-2A IN ADVANCED COLORECTAL-CANCER, British Journal of Cancer, 74(6), 1996, pp. 971-974
Risultati: 1-7 |